State of the science/evidence base for integrative modalities
Secondary Topic: Whole systems and acupuncture (including TCM and Ayurveda)
Tertiary Topic: Research Methodology
Acupuncture in the treatment of pain in patients with Sickle Cell Disease
Late Breaker: Yes
Sickle cell disease (SCD) is the genetic hematologic disease most prevalent in the world. Individuals with SCD can have acute pain crises or chronic pain as aseptic necrosis. The medical literature about the use of acupuncture in these patients is very scarce.
Treatment of acupuncture was offered to patients with SCD who expected routine medical consultation at the Hereditary Anemia Outpatient Clinic of UNIFESP. Just patients with chronic or acute pain at the time of service were included. The Analog Scale of Pain (ASP) was detected in 3 moments: before, soon after application and after withdrawal of needles with 15 minutes of stay. Three acupuncture points, developed by Prof Dr Ysao Yamamura, were used: craniometrico Pterio, craniometrico Lambda, and Nasal Microsystem. A week later, made telephone contact for updating the intensity of pain. In the second week just with those who remained without pain. The results were assessed in spss using T-test for one sample, the Chi square test, anova and test of Turkey.
26 patients with SCD were assisted, with 28 complaints, because a patient presented pain in 3 different places simultaneously. The median intensity before acupuntura by ASP was 7 (2 to 10); 43% of the pains had until 7 days long. All showed reduction in pain intensity, and 86% were asymptomatic after the medical attendance.
Acupuncture was beneficial to all patients, by reducing or eliminating pain. It is an analgesic tool more lasting than any conventional medication. A study with a control group would be necessary to increase the power of evidence of the effectiveness of acupuncture in patients.